# Thyroid Cancer Anaplastic thyroid cancer is one of the most aggressive solid tumours. That alone makes any plausible new mechanism worth attention. For shikonin, the main thyroid-cancer signal is ferroptosis. ### Why thyroid cancer is a logical target Ferroptosis-vulnerable tumours tend to show high oxidative stress pressure and susceptibility to lipid peroxidation. Anaplastic thyroid-cancer cells may fit that profile. Shikonin appears able to exploit it. ### Key evidence In anaplastic thyroid-cancer cell lines, shikonin reduced cell growth and induced ferroptosis. The mechanism was supported by lipid-peroxidation markers and reversal with ferroptosis inhibitors. That is important because it distinguishes ferroptosis from generic oxidative injury claims. ### Why this matters This is the clearest cancer-type setting where ferroptosis is the central shikonin story rather than a side note. That gives thyroid cancer a distinctive place in the wider evidence set. ### Limits * evidence is mainly one recent study * no animal validation exists yet * no data in papillary or follicular thyroid cancer * no interaction data with lenvatinib, pembrolizumab, or other current ATC treatments ### Bottom line The thyroid-cancer evidence is promising but still very thin. It is worth tracking because the mechanism is specific and the unmet need is high. It is not yet a robust evidence area. ### References Shikonin inhibits the growth of anaplastic thyroid carcinoma cells via ferroptosis. *Heliyon / ScienceDirect* (2024).\ {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/thyroid-cancer.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.